ALTO-100 in MDD and/or PTSD
Study sponsor: Alto Neuroscience
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-12-01Actual
Enrollment · participants245Actual
Source updated2023-12-01Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.